The pharmaceutical industry is experiencing a significant shift in diabetes care with the arrival of GLP-1 transdermal devices. These groundbreaking methods offer a possibly easy alternative to subcutaneous injections for individuals living with diabetes mellitus type 2. By avoiding the requirement for frequent injections, GLP-1 adhesives promis… Read More